The stock's fall snapped a two-day winning streak.
Shares of Novavax Inc. NVAX slid 3.18% to $7.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to 17,436.10 ...
Novavax (NasdaqGS:NVAX) recently announced its earnings for Q4 2024, showing a significant improvement in net loss and loss per share, which may have positively influenced its stock price movement ...
Novavax, Inc. (Nasdaq: NVAX) today announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed as his successor. The Company also appointed ...
Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...
We have no idea. We can’t speculate on what didn’t happen.” While Taylor indicated that Novavax’s technology made its vaccine an attractive option, it may also have delayed its development.
After hours: March 12 at 7:53:13 p.m. EDT Loading Chart for NVAX ...
The famous apple logo with the bitten apple has become one of the most recognisable symbols in the world. It is a symbol of innovation, quality and excellence. Apple Inc. is a technology giant that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results